References (Continued, Page 2)

Cohn, J. B., Collins, G., Ashbrook, E., & Wernicke, J. F. (1989). A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder. International Clinical Psychopharmacology, 4, 313–322.

Cole, J. O., & Davis, J. M. (1969). Antipsychotic drugs. In The schizophrenia syndrome (pp. 478-568). Grune & Stratton.

Collazo, Y., Tam, R., Sramek, J., & Herrera, J. (1996). Neuroleptic dosing in Hispanic and Asian inpatients with schizophrenia. Mt. Sinai Journal of Medicine, 63, 310–313.

Conrad, K. J., Matters, M. D., Hanrahan, P., Luchins, D. J., Savage, C., & Daugherty, B. (1998). Characteristics of persons with mental illness in a representative payee program. Psychiatric Services, 49, 1223–1225.

Conwell, Y., & Brent, D. (1995). Suicide and aging. I: Patterns of psychiatric diagnosis. International Psychogeriatrics, 2, 149–164.

Cook, J. A., & Jonikas, J. A. (1996). Outcomes of psychiatric rehabilitation service delivery. New Directions in Mental Health Services, 71, 33–47.

Cook, J. A., & Solomon, M. L. (1993). The Community Scholar Program: An outcome study of supported education for students with severe mental illness. Psychosocial Rehabilitation Journal, 17, 83–97.

Cook, J. A., Wessell, M., & Dincin, J. (1987). Predicting educational levels of the severely mentally ill: Implications for psychosocial program directors. Psychosocial Rehabilitation Journal, 11, 23–37.

Cook, M., & Mineka, S. (1989). Observational conditioning of fear to fear-relevant vs. fear-irrelevant stimuli in rhesus monkeys. Journal of Abnormal Psychology, 98, 448–459.

Coplan, J. D., & Lydiard, R. B. (1998). Brain circuits in panic disorder. Biological Psychiatry, 44, 1264–1276.

Coplan, J. D., Pine, D. S., Papp, L. A., & Gorman, J. M. (1997). A view on noradrenergic, hypothalamic-pituitary-adrenal axis and extrahypothalamic corticotrophin-releasing factor function in anxiety and affective disorders: The reduced growth hormone response to clonidine. Psychopharmacology Bulletin, 33, 193–204.

Cornblatt, B. A., & Keilp, J. G. (1994). Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophrenia Bulletin, 20, 31–46.

Coryell, W., Endicott, J., & Keller, M. (1992). Rapidly cycling affective disorder. Demographics, diagnosis, family history, and course. Archives of General Psychiatry, 49, 126–131.

Coryell, W., Solomon, D., Leon, A. C., Akiskal, H. S., Keller, M. B., Scheftner, W. A., & Mueller, T. (1998). Lithium discontinuation and subsequent effectiveness. American Journal of Psychiatry, 155, 895–898.

Cournos, F., & McKinnon, K. (1997). HIV seroprevalence among people with severe mental illness in the United States: A critical review. Clinical Psychology Review, 17, 259–269.

Coxhead, N., Silverstone, T., & Cookson, J. (1992). Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder. Acta Psychiatrica Scandinavica, 85, 114–118.

Crismon, M. L., Trivedi, M., Pigott, T. A., Rush, A. J., Hirschfeld, R. M., Kahn, D. A., DeBattista, C., Nelson, J. C., Nierenberg, A. A., Sackeim, H. A., & Thase, M. A. (1999). The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. Journal of Clinical Psychiatry, 60, 142–156.

Crow, T. J. (1985). The two-syndrome concept: Origins and current status. Schizophrenia Bulletin, 11, 471–486.

Crow, T. J. (1995). Brain changes and negative symptoms in schizophrenia. Psychopathology, 28, 18–21.

Csernansky, J. G., & Grace, A. A. (1998). New models of the pathophysiology of schizophrenia: Editors' introduction. Schizophrenia Bulletin, 24, 185–187.

Cuesta, M. J., & Peralta, V. (1995). Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia. Psychiatry Research, 58, 227–235.

Danish University Antidepressant Group. (1986). Citalopram: Clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology (Berlin), 90, 131–138.

Danish University Antidepressant Group. (1990). Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance but weaker antidepressant effect than clomipramine in a controlled multicenter study. Journal of Affective Disorders, 18, 289–299.

Dassori, A. M., Miller, A. L., & Saldana, D. (1995). Schizophrenia among Hispanics: Epidemiology, phenomenology, course, and outcome. Schizophrenia Bulletin, 21, 303–312.

Davidson, J. (1989). Seizures and bupropion: A review. Journal of Clinical Psychiatry, 50, 256-261.

Davidson, J. R. (1998). Pharmacotherapy of social anxiety disorder. Journal of Clinical Psychiatry, 59(Suppl. 17), 47–53.

Davis, J. M., Barter, J. T., & Kane, J. M. (1989). The natural course of schizophrenia and effective maintenance drug treatment. In H. I. Kaplan & B. J. Sadock (Eds.), Comprehensive textbook of psychiatry (Vol. 5, pp. 1591–1626). Baltimore: Williams & Wilkins.

Davis, M. (1997). Neurobiology of fear responses: The role of the amygdala. Journal of Neuropsychiatry and Clinical Neurosciences, 9, 382–402.

Dawlans, K. (1995). Gender differences in psychiatry: Epidemiology and drug response. CNS Drugs, 3, 393–407.

de Kloet, E. R., Rots, N. Y., & Cools, A. R. (1996). Brain-corticosteroid hormone dialogue: Slow and persistent. Cellular and Molecular Neurobiology, 16, 345–356.

DeJong R., Treiber R., & Henrich G. (1986). Effectiveness of two psychological treatments for inpatients with severe and chronic depression. Cognitive Therapy and Research, 10, 645–663.

Deltito, J., & Beyer, D. (1998). The scientific, quasi-scientific and popular literature on the use of St. John's Wort in the treatment of depression. Journal of Affective Disorders, 51, 341–351.

Depression Guideline Panel. (1993). Clinical practice guideline number 5: Depression in primary care II (AHRQ Publication No. 93-0551). Rockville, MD: U.S. Department of Health and Human Services.

DeQuardo, J. R., Goldman, M., & Tandon, R. (1996). VBR in schizophrenia: Relationship to family history of psychosis and season of birth. Schizophrenia Research, 20, 275–285.

DeSisto, M., Harding, C. M., McCormick, R. V., Ashikaga, T., & Brooks, G. W. (1995a). The Maine and Vermont three-decade studies of serious mental illness: I. Matched comparison of cross-sectional outcome. British Journal of Psychiatry, 167, 331–342.

DeSisto, M., Harding, C. M., McCormick, R. V., Ashikaga, T., & Brooks, G. W. (1995b). The Maine and Vermont three-decade studies of serious mental illness: II. Longitudinal course. British Journal of Psychiatry, 167, 331–342.

Devanand, D. P., Dwork, A. J., Hutchinson, E. R., Bolwig, T. G., & Sackeim, H. A. (1994). Does ECT alter brain structure? American Journal of Psychiatry, 151, 957–970.

DeVane, C. L. (1992). Pharmacokinetics of the selective serotonin reuptake inhibitors. Journal of Clinical Psychiatry, 53(Suppl.), 13–20.

DiMascio, A., Klerman, G. L., Weissman, M. M., Prusoff, B. A., Neu, C., & Moore, P. (1979). A control group for psychotherapy research in acute depression: One solution to ethical and methodologic issues. Journal of Psychiatric Research, 15, 189–197.

Dincin, J. (1975). Psychiatric rehabilitation. Schizophrenia Bulletin, 13, 131–147.

Dincin, J., & Witheridge, T. F. (1982). Psychiatric rehabilitation as a deterrent to recividism. Hospital and Community Psychiatry, 33, 645–650.

Dixon, L. B., Hackman, A., & Lehman, A. F. (1997). Consumers as staff in assertive community treatment programs. Administration and Policy in Mental Health, 25, 199–208.

Dixon, L. B., Lehman, A. F., & Levine, J. (1995). Conventional antipsychotic medications for schizophrenia. Schizophrenia Bulletin, 21, 567–577.

Dixon, L., Postrado, L., Delahanty, J., Fischer, P. J., & Lehman, A. (1999). The association of medical comorbidity in schizophrenia with poor physical and mental health. Journal of Nervous and Mental Disease, 187, 496–502.

Dixon, L. B., Stewart, B., Krauss, N., Robbins, J., Hackman, A., & Lehman, A. F. (1998). The participation of families of homeless persons with severe mental illness in an outreach intervention. Community Mental Health Journal, 34, 251–259.

Dixon, L., Weiden, P., Delahanty, J., Goldberg, R., Postrado, L., Lucksted, A., & Lehman, A. (in press-a). Diabetes and schizophrenia. Schizophrenia Bulletin.

Dixon, L., Wohlheiter, K., & Thompson, D. (in press-b). Medical management of schizophrenia. In J. Lieberman & R. Murray (Eds.), Comprehensive care of schizophrenia. London: Martin Dunitz Publishers.

Dobson, K. S. (1989). A meta-analysis of the efficacy of cognitive therapy for depression. Journal of Consulting and Clinical Psychology, 57, 414–419.

Docherty, N. M., DeRosa, M., & Andreasen, N. C. (1996). Communication disturbances in schizophrenia and mania. Archives of General Psychiatry, 53, 358–364.

Donlon, P. T., Hopkin, J. T., Tupin, J. P., Wicks, J. J., Wahba, M., & Meadow, A. (1980). Haloperidol for acute schizophrenic patients. An evaluation of three oral regimens. Archives of General Psychiatry, 37, 691–695.

Donlon, P. T., Meadow, A., Tupin, J. P., & Wahba, M. (1978). High vs standard dosage fluphenazine HCL in acute schizophrenia. Journal of Clinical Psychiatry, 39, 800–804.

Doogan, D. P., & Caillard, V. (1992). Sertraline in the prevention of depression. British Journal of Psychiatry, 160, 217–222.

Drake, R.E., Becker, D. R., Biesanz, J. C., Torrey, W. C., McHugo, G.J., & Wyzik, P. F. (1994). Rehabilitative day treatment vs. supported employment: I. Vocational outcomes. Community Mental Health Journal, 30, 519–532.

Drake, R. E., Becker, D. R., Biesanz, J. C., Wyzik, P. F., & Torrey, W. C. (1996). Day treatment versus supported employment for persons with severe mental illness: A replication study. Psychiatric Services, 47, 1125–1127.

Drake, R. E., Mercer-McFadden, C., Mueser, K. T., McHugo, G. J., & Bond, G. R. (1998). Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin, 24, 589–608.

Drake, R. E., & Osher, F. C. (1997). Treating substance abuse in patients with severe mental illness. In S. W. Henggeler & A. B. Santos (Eds.), Innovative approaches for difficult-to-treat populations (pp. 239–252). Washington, DC: American Psychiatric Press.

Drevets, W. C. (1998). Functional neuroimaging studies of depression: The anatomy of melancholia. Annual Review of Medicine, 49, 341–361.

Drury, V., Birchwood, M., Cochrane, R., & Macmillan, F. (1996). Cognitive therapy and recovery from acute psychosis: A controlled trial: II. Impact on recovery time. British Journal of Psychiatry, 169, 602–607.

Druss, B. G., & Rosenheck, R. A. (1998). Mental disorders and access to medical care in the United States. American Journal of Psychiatry, 155, 1775–1777.

DSM-IV. See American Psychiatric Association (1994).

Duboff, E. A. (1993). Long-term treatment of major depressive disorder with paroxetine. Journal of Clinical Psychopharmacology, 13(Suppl. 2), 28S–33S.

Dubovsky, S. L., Franks, R. D., Allen, S., & Murphy, J. (1986). Calcium antagonists in mania: A double-blind study of verapamil. Psychiatry Research, 18, 309–320.

Dubovsky, S. L., Murphy, J., Thomas, M., & Rademacher, J. (1992). Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. American Journal of Psychiatry, 149, 118–120.

Duman, R. S., Heninger, G. R., & Nestler, E. J. (1997). A molecular and cellular theory of depression. Archives of General Psychiatry, 54, 597–606.

Dykes, K. L., Mednick, S. A., Machon, R. A., Praestholm, J., & Parnas, J. (1992). Adult third ventricle width and infant behavioral arousal in groups at high and low risk for schizophrenia. Schizophrenia Research, 7, 13–18.

Eaton, W. W., Thara, R., Federman, B., Melton, B., & Liang, K. Y. (1995). Structure and course of positive and negative symptoms in schizophrenia. Archives of General Psychiatry, 52, 127–134.

Egeland, J. A., Hostetter, A. M., & Eshleman, S. K., III. (1983). Amish study, III: The impact of cultural factors on diagnosis of bipolar illness. American Journal of Psychiatry, 140, 67–71.

Eisenstat, S. A., & Bancroft, L. (1999). Domestic violence. New England Journal of Medicine, 341, 886–892.

el-Bayoumi, G., Borum, M. L., & Haywood, Y. (1998). Domestic violence in women. Medical Clinics of North America, 82, 391–401.

Elkin, I., Shea, M. T., Watkins, J. T., Imber, S. D., Sotsky, S. M., Collins, J. F., Glass, D. R., Pilkonis, P. A., Leber, W. R., Docherty, J. P., Fiester, S. J., & Parloff, M. B. (1989). National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Archives of General Psychiatry, 46, 971–982.

Ellenbroek, B. A., & Cools, A. R. (1998). Mini-review. The neurodevelopmental hypothesis of schizophrenia: Clinical evidence and animal models. Neuroscience Research Communications, 22, 127–136.

Erikson, E. (1963). Childhood and society. New York: W. W. Norton.

Evans, M. D., Hollon, S. D., DeRubeis, R. J., Piasecki, J. M., Grove, W. M., Garvey, M. J., & Tuason, V. B. (1992). Differential relapse following cognitive therapy and pharmacotherapy for depression. Archives of General Psychiatry, 49, 802–808.

Eysenck, H. K., & Eysenck, S. B. (1975). Eysenck personality questionnaire manual. San Diego: Educational and Industrial Testing Service.

Fabian, E., Waterworth, A., & Ripka, B. (1993). Reasonable accommodation for workers with serious mental illness: Type frequency and associated outcomes. Psychosocial Rehabilitation Journal, 17, 163–172.

Fairweather, G. W., Sanders, D. H., Maynard, H., Cressler, D. L., & Bleck, D. S. (1969). Community life for the mentally ill: An alternative to institutional care. Chicago: Aldine.

Falkai, P., Schneider, T., Greve, B., Klieser, E., & Bogerts, B. (1995). Reduced frontal and occipital lobe asymmetry on the CT-scans of schizophrenic patients. Its specificity and clinical significance. Journal of Neural Transmission. General Section, 99, 63–77.

Falloon, I. R. (1984). Relapse: A reappraisal of assessment of outcome in schizophrenia. Schizophrenia Bulletin, 10, 293–299.

Falloon, I. R., Boyd, J. L., McGill, C. W., Williamson, M., Razani, J., Moss, H.B., Gilderman, A. M., & Simpson, G. M. (1985). Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two-year longitudinal study. Archives of General Psychiatry, 42, 887–896.

Fava, M., & Rosenbaum, J. F. (1991). Suicidality and fluoxetine: Is there a relationship? Journal of Clinical Psychiatry, 52, 108–111.

Fawcett, J., Epstein, P., Fiester, S. J., Elkin, I., & Autry, J. H. (1987). Clinical management—imipramine/placebo administration manual. NIMH Treatment of Depression Collaborative Research Program. Psychopharmacology Bulletin, 23, 309–324.

Federal Interagency Task Force on Homelessness and Mental Illness. (1992). Outcasts on Main Street. Washington, DC: Federal Interagency Task Force on Homelessness and Mental Illness.

Feighner, J. P. (1999). Mechanism of action of antidepressant medications. Journal of Clinical Psychiatry, 60(Suppl. 4), 4–11.

Felker, B., Yazel, J. J., & Short, D. (1996). Mortality and medical comorbidity among psychiatry patients: A review. Psychiatric Services, 47, 1356–1363.

Felton, C. J., Stastny, P., Shern, D. L., Blanch, A., Donahue, S. A., Knight, E., & Brown, C. (1995). Consumers as peer specialists on intensive case management teams: Impact on client outcomes. Psychiatric Services, 46, 1037–1044.

Fenton, W. S., & Kane, J. M. (1997). Clinical challenges in the psychopharmacology of schizophrenia. Schizophrenia Bulletin, 23, 563–565.

Fenton, W., Mosher, L., Herrell, J., & Blyler, C. (1998). A randomized trial of general hospital versus residential alternative care for patients with severe and persistent mental illness. American Journal of Psychiatry, 155, 516–522.

Fleischhacker, W. W., & Hummer, M. (1997). Drug treatment of schizophrenia in the 1990s. Achievements and future possibilities in optimizing outcomes. Drugs, 53, 915–929.

Flynn, L. M. (1998). Patterns of usual care for schizophrenia: Initial results from the Schizophrenia Patient Outcomes Research Team (PORT) client survey. Commentary. Schizophrenia Bulletin, 24, 30–32.

Foster, R. H., & Goa, K. L. (1998). Risperidone—a pharmacoeconomic review of its use in schizophrenia. Pharmacoeconomics, 14, 97–133.

Frackiewicz, E. J., Sramek, J. J., Herrera, J. M., Kurtz, N. M., & Cutler, N. R. (1997). Ethnicity and antipsychotic response. Annals of Pharmacotherapy, 31, 1360–1369.

Frances, A., Docherty, P., & Kahn, A. (1996). Treatment of schizophrenia. Journal of Clinical Psychiatry, 57, 1–59.

Franchini, L., Gasperini, M., Perez, J., Smeraldi, E., & Zanardi, R. (1997). A double-blind study of long-term treatment with sertraline or fluvoxamine for prevention of highly recurrent unipolar depression. Journal of Clinical Psychiatry, 58, 104–107.

Frank, E., Anderson, B., Reynolds, C. F., III, Ritenour, A., & Kupfer, D. J. (1994). Life events and the research diagnostic criteria endogenous subtype. A confirmation of the distinction using the Bedford College methods. Archives of General Psychiatry, 51, 519–524.

Frank, E., Kupfer, D. J., Perel, J. M., Cornes, C., Jarrett, D. B., Mallinger, A. G., Thase, M. E., McEachran, A. B., & Grochocinski, V. J. (1990). Three-year outcomes for maintenance therapies in recurrent depression. Archives of General Psychiatry, 47, 1093–1099.

Frank, E., Kupfer, D. J., Perel, J. M., Cornes, C., Mallinger, A. G., Thase, M. E., McEachran, A. B., & Grochocinski, V. J. (1993). Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression. Journal of Affective Disorders, 27, 139–145.

Frank, E., Kupfer, D. J., Wagner, E. F., McEachran, A. B., & Cornes, C. (1991a). Efficacy of interpersonal psychotherapy as a maintenance treatment of recurrent depression. Contributing factors. Archives of General Psychiatry, 48, 1053–1059.

Frank, E., Prien, R. F., Jarrett, R. B., Keller, M. B., Kupfer, D. J., Lavori, P. W., Rush, A. J., & Weissman, M. M. (1991b). Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Archives of General Psychiatry, 48, 851–855.

Freeman, T. W., Clothier, J. L., Pazzaglia, P., Lesem, M. D., & Swann, A. C. (1992). A double-blind comparison of valproate and lithium in the treatment of acute mania. American Journal of Psychiatry, 149, 108–111.

Fukuzako, H., Fukuzako, T., Takeuchi, K., Ohbo, Y., Ueyama, K., Takigawa, M., & Fujimoto, T. (1996). Phosphorus magnetic resonance spectroscopy in schizophrenia: Correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms. Progress in Neuropsychopharmacology and Biological Psychiatry, 20, 629–640.

Gaebel, W., Frick, U., Kopcke, W., Linden, M., Muller, P., Muller-Spahn, F., Pietzcker, A., & Tegeler, J. (1993). Early neuroleptic intervention in schizophrenia: Are prodromal symptoms valid predictors of relapse? British Journal of Psychiatry. Supplement, 21, 8–12.

Galanter, M. (1988). Zealous self-help groups as adjuncts to psychiatric treatment: A study of Recovery, Inc. American Journal of Psychiatry, 145, 1248–1253.

Gallhofer, B., Bauer, U., Lis, S., Krieger, S., & Gruppe, H. (1996). Cognitive dysfunction in schizophrenia: Comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs. European Neuropsychopharmacology, 6(Suppl. 2), S13–S20.

Gardner, E. A., & Johnston, J. A. (1985). Bupropion—An antidepressant without sexual pathophysiological action. Journal of Clinical Psychopharmacology, 5, 24–29.

Garza-Trevino, E. S., Overall, J. E., & Hollister, L. E. (1992). Verapamil versus lithium in acute mania. American Journal of Psychiatry, 149, 121–122.

Gelenberg, A. J., Kane, J. M., Keller, M. B., Lavori, P., Rosenbaum, J. F., Cole, K., & Lavelle, J. (1989). Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. New England Journal of Medicine, 321, 1489–1493.

General Accounting Office. (1977). Returning the mentally disabled to the community: Government needs to do more. Washington, DC: Author.

Gerbaldo, H., Cassady, S., & Helisch, A. (1995). Negative symptoms and the course of positive symptoms in deficit schizophrenia. Psychopathology, 28, 121-126.

Gerber, P. D., Barrett, J., Manheimer, E., Whiting, R., & Smith, R. (1989). Recognition of depression by internists in primary care: A comparison of internist and "gold standard" psychiatric assessments. Journal of General Internal Medicine, 4, 7–13.

Geyer, M. A., Wilkinson, L. S., Humby, T., & Robbins, T. W. (1993). Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biological Psychiatry, 34, 361–372.

Glassman, A. H., & Shapiro, P. A. (1998). Depression in the course of coronary artery disease. American Journal of Psychiatry, 155, 4–11.

Goddard, A. W., & Charney, D. S. (1997). Toward an integrated neurobiology of panic disorder. Journal of Clinical Psychiatry, 58(Suppl. 2), 4–11.

Goldberg, D. P., & Lecrubier, Y. (1995). Form and frequency of mental disorders across centres. In T. B. Ustun & N. Sartorius (Eds.), Mental illness in general health care: An international study (pp. 323–334). New York: John Wiley & Sons.

Goldman, H. H. (1998a). Deinstitutionalization and community care: Social welfare policy as mental health policy. Harvard Review of Psychiatry, 6, 219–222.

Goldman, H. H. (1998b). Organizing mental health services: An evidence-based approach. Stockholm: Swedish Council on Technology Assessment in Health Care.

Goldman, H. H. (1999). The obligation of mental health services to the least well off. Psychiatric Services, 50, 659–663.

Goldman, H., Lehman, A., Morrissey, J., Newman, S., Frank, R., & Steinwachs, D. (1990a). Design for the national evaluation of the Robert Wood Johnson Foundation program on chronic mental illness. Hospital and Community Psychiatry, 41, 1217–1221.

Goldman, H., Morrissey, J., & Ridgely, M. S. (1990b). Form and function of mental health authorities at RWJ Foundation program sites: Preliminary observations. Hospital and Community Psychiatry, 41, 1222–1230.

Goldman, H. H., Morrissey, J. P., & Ridgely, M. S. (1994a). Evaluating the Robert Wood Johnson Foundation program on chronic mental illness. Milbank Quarterly, 72, 37–47.

Goldman, H., Morrissey, J., & Ridgely, M. S. (1994b). Evaluating the program on chronic mental illness (RWJ PCMI). Milbank Quarterly, 72, 37–48.

Goldman-Rakic, P. S., & Selemon, L. D. (1997). Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophrenia Bulletin, 23, 437–458.

Goldstein, M. J. (1995a). Psychoeducation and relapse prevention. International Clinical Psychopharmacology, 9(Suppl. 5), 59–69.

Goldstein, M. J. (1995b). Transactional processes associated with relatives' expressed emotion. International Journal of Mental Health, 24, 76–96.

Goldstein, M. J., Rodnick, E. H., Evans, J. R., May, P. R., & Steinberg, M. R. (1978). Drug and family therapy in the aftercare of acute schizophrenics. Archives of General Psychiatry, 35, 1169–1177.

Goodman, L. A., Rosenberg, S. D., Mueser, K. T., & Drake, R. E. (1997). Physical and sexual assault history in women with serious mental illness: Prevalence, correlates, treatment, and future research directions. Schizophrenia Bulletin, 23, 685–696.

Goodnick, P. J., & Extein, I. L. (1989). Bupropion and fluoxetine in depressive subtypes. Annals of Clinical Psychiatry, 1, 119–122.

Goodwin, F., & Jamison, K. (1990). Manic-depressive illness. New York: Oxford University Press.

Gorman, J. M., & Coplan, J. D. (1996). Comorbidity of depression and panic disorder. Journal of Clinical Psychiatry, 57(Suppl. 10), 34–43.

Gottesman, I. I. (1991). Schizophrenia genesis—The origins of madness. New York: W. H. Freeman.

Grace, A. A. (1991). Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience, 41, 1–24.

Grace, A. A. (1992). The depolarization block hypothesis of neuroleptic action: Implications for the etiology and treatment of schizophrenia. Journal of Neural Transmission. Supplementum, 36, 91–131.

Green, M. F., Marshall, B. D., Jr., Wirshing, W. C., Ames, D., Marder, S. R., McGurk, S., Kern, R. S., & Mintz, J. (1997). Does risperidone improve verbal working memory in treatment-resistant schizophrenia? American Journal of Psychiatry, 154, 799–804.

Greenberg, P. E., Stiglin, L. E., Finkelstein, S. N., & Berndt, E. R. (1993). The economic burden of depression in 1990. Journal of Clinical Psychiatry, 54, 405–418.

Greenberg, R. M. (1997). ECT in the elderly. New Directions in Mental Health Services, 76, 85–96.

Greist, J. H., Jefferson, J. W., Kobak, K. A., Katzelnick, D. J., & Serlin, R. C. (1995). Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. Archives of General Psychiatry, 52, 53–60.

Gruenberg, E. (1974). The social breakdown syndrome and its prevention. In S. Arieti (Ed.), American handbook of psychiatry (2nd ed., pp. 697–711). New York: Basic Books.

Guarnaccia, P. J., Parra, P., Deschamps, A., Milstein, G., & Argiles, N. (1992). Si dios quiere: Hispanic families' experiences of caring for a seriously mentally ill family member. Culture, Medicine and Psychiatry, 16, 187–215.

Guelfi, J. D., White, C., Hackett, D., Guichoux, J. Y., & Magni, G. (1995). Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia. Journal of Clinical Psychiatry, 56, 450–458.

Gunasekara, N. A., & Spencer, C. M. (1998). Quetiapine—A review of its use in schizophrenia. Central Nervous System Drugs, 9, 325–340.

Gunderson, J. G., Frank, A. F., Katz, H. M., Vannicelli, M. L., Frosch, J. P., & Knapp, P. H. (1984). Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophrenia Bulletin, 10, 564–598.

Gupta, S., Andreasen, N. C., Arndt, S., Flaum, M., Hubbard, W. C., & Ziebell, S. (1997). The Iowa longitudinal study of recent onset psychosis: One-year follow-up of first episode patients. Schizophrenia Research, 23, 1–13.

Hafner, H., & an der Heiden, W. (1997). Epidemiology of schizophrenia. Canadian Journal of Psychiatry, 42, 139–151.

Hafner, H., an der Heiden, W., Behrens, S., Gattaz, W. F., Hambrecht, M., Loffler, W., Maurer, K., Munk-Jorgensen, P., Nowotny, B., Riecher-Rossler, A., & Stein, A. (1998). Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophrenia Bulletin, 24, 99–113.

Hamera, E. K., Peterson, K. A., Young, L. M., & Schaumloffel, M. M. (1992). Symptom monitoring in schizophrenia: Potential for enhancing self-care. Archives of Psychiatric Nursing, 6, 324–330.

Harding, C. M., Brooks, G. W., Ashikaga, T., Strauss, J. S., & Breier, A. (1987). The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. American Journal of Psychiatry, 144, 727–735.

Harding, C., Strauss, J. S., & Zubin, J. (1992). Chronicity in schizophrenia: Revisited. British Journal of Psychiatry, 161, 27–37.

Harrow, M., Sands, J. R., Silverstein, M. L., & Goldberg, J. F. (1997). Course and outcome for schizophrenia versus other psychotic patients: A longitudinal study. Schizophrenia Bulletin, 23, 287–303.

Harvey, P. D., Lombardi, J., Leibman, M., White, L., Parella, M., Powchik, P., & Davidson, M. (1996). Cognitive impairment and negative symptoms in geriatric chronic schizophrenic patients: A follow-up study. Schizophrenia Research, 22, 223–231.

Hasan, S., & Buckley, P. (1998). Novel antipsychotics and the neuroleptic malignant syndrome: A review and critique. American Journal of Psychiatry, 155, 1113–1116.

Hatfield, A. B. (1992). Leaving home: Separation issues in psychiatric illness. Psychosocial Rehabilitation Journal, 15, 37–47.

Hatfield, A. B., Spaniol, L., & Zipple, A. M. (1987). Expressed emotion: A family perspective. Schizophrenia Bulletin, 13, 221–226.

Havassy, B. E., & Arns, P. G. (1998). Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients. Psychiatric Services, 49, 935–940.

Haykal, R. F., & Akiskal, H. S. (1990). Bupropion as a promising approach to rapid cycling bipolar II patients. Journal of Clinical Psychiatry, 51, 450–455.

Heller, T., Roccoforte, J. A., & Cook, J. A. (1997a). Predictors of support group participation among families of persons with mental illness. Family Relations, 46, 437–442.

Heller, T., Roccoforte, J. A., Hsieh, K., Cook, J. A., & Pickett, S. A. (1997b). Benefits of support groups for families of adults with severe mental illness. American Journal of Orthopsychiatry, 67, 187–198.

Helzer, J. E., Robins, L. N., & McEvoy, L. (1987). Post-traumatic stress disorder in the general population. Findings of the Epidemiologic Catchment Area survey. New England Journal of Medicine, 317, 1630–1634.

Hermann, R. C., Dorwart, R. A., Hoover, C. W., & Brody, J. (1995). Variation in ECT use in the United States. American Journal of Psychiatry, 152, 869–875.

Hermann, R. C., Ettner, S. L., Dorwart, R. A., Langman-Dorwart, N., & Kleinman, S. (1999). Diagnoses of patients treated with ECT: A comparison of evidence-based standards with reported use. Psychiatric Services, 50, 1059–1065.

Herz, M. I., & Lamberti, J. S. (1995). Prodromal symptoms and relapse prevention in schizophrenia. Schizophrenia Bulletin, 21, 541–551.

Herz, M. I., & Melville, C. (1980). Relapse in schizophrenia. American Journal of Psychiatry, 137, 801–805.

Himmelhoch, J. M., Thase, M. E., Mallinger, A. G., & Houck, P. (1991). Tranylcypromine versus imipramine in anergic bipolar depression. American Journal of Psychiatry, 148, 910–916.

Hirschfeld, R. M., Keller, M. B., Panico, S., Arons, B. S., Barlow, D., Davidoff, F., Endicott, J., Froom, J., Goldstein, M., Gorman, J. M., Marek, R. G., Maurer, T. A., Meyer, R., Phillips, K., Ross, J., Schwenk, T. L., Sharfstein, S. S., Thase, M. E., & Wyatt, R. J. (1997). The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. Journal of the American Medical Association, 277, 333–340.

Hirschfeld, R., & Shea, T. (1992). Personality. In E. Paykel (Ed.), Handbook of affective disorders (pp. 185–194). New York: Guilford Press.

Ho, B. C., Andreasen, N., & Flaum, M. (1997). Dependence on public financial support early in the course of schizophrenia. Psychiatric Services, 48, 948–950.

Ho, B. C., Nopoulos, P., Flaum, M., Arndt, S., & Andreasen, N. C. (1998). Two-year outcome in first-episode schizophrenia: Predictive value of symptoms for quality of life. American Journal of Psychiatry, 155, 1196–1201.

Hoffman, F. L., & Mastrianni, X. (1993). The role of supported education in the inpatient treatment of young adults: A two-site comparison. Psychosocial Rehabilitation Journal, 17, 109–119.

Hogarty, G. E., Anderson, C. M., & Reiss, D. J. (1987). Family psychoeducation, social skills training, and medication in schizophrenia: The long and short of it. Psychopharmacology Bulletin, 23, 12–13.

Hogarty, G. E., Greenwald, D., Ulrich, R. F., Kornblith, S. J., DiBarry, A. L., Cooley, S., Carter, M., & Flesher, S. (1997). Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry, 154, 1514–1524.

Hollander, E. (1996). Obsessive-compulsive disorder-related disorders: The role of selective serotonergic reuptake inhibitors. International Clinical Psychopharmacology, 11(Suppl. 5), 75–87.

Hollister, J. M., Laing, P., & Mednick, S. A. (1996). Rhesus incompatibility as a risk factor for schizophrenia in male adults. Archives of General Psychiatry, 53, 19–24.

Hollon, S. D., DeRubeis, R. J., Evans, M. D., Wiemer, M. J., Garvey, M. J., Grove, W. M., & Tuason, V. B. (1992). Cognitive therapy and pharmacotherapy for depression. Singly and in combination. Archives of General Psychiatry, 49, 774–781.

Holmes, T. H., & Rahe, R. H. (1967). The social readjustment rating scale. Journal of Psychosomatic Research, 11, 213–218.

Hornig, C. D., & McNally, R. J. (1995). Panic disorder and suicide attempt. A reanalysis of data from the Epidemiologic Catchment Area study. British Journal of Psychiatry, 167, 76–79.

Horne, R. L., Pettinati, H. M., Sugerman, A. A., & Varga, E. (1985). Comparing bilateral to unilateral electroconvulsive therapy in a randomized study with EEG montoring. Archives of General Psychiatry, 42, 1087–1092.

Howland, R. H., & Thase, M. E. (1993). A comprehensive review of cyclothymic disorder. Journal of Nervous and Mental Disease, 181, 485–493.

Hu, T. W., Snowden, L. R., Jerrell, J. M., & Nguyen, T. D. (1991). Ethnic populations in public mental health: Services choice and level of use. American Journal of Public Health, 81, 1429–1434.

---

Back to Top

Home | Contents | Previous | Next